Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non–Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials

PURPOSE: The impact of epidermal growth factor receptor (EGFR) and KRAS genotypes on outcomes with erlotinib or gefitinib therapy continues to be debated. This study combines patient data from five trials in predominantly Western populations to assess the impact of EGFR and KRAS mutations on first-l...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Jackman, David M., Miller, Vincent A., Cioffredi, Leigh-Anne, Yeap, Beow Y., Jänne, Pasi A., Riely, Gregory J., Ruiz, Marielle Gallegos, Giaccone, Giuseppe, Sequist, Lecia V., Johnson, Bruce E.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2009
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3219530/
https://ncbi.nlm.nih.gov/pubmed/19671843
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-0888
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items